Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 2

Sponsor Class

OTHER 16INDUSTRY 10NIH 2FED 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Classical hematology 2Gynecologic 1Breast 1

Conditions

Anemia, Refractory, with Excess of Blasts 50Myelodysplastic Syndromes 40Leukemia, Myeloid, Acute 34Leukemia, Myelomonocytic, Chronic 33Leukemia 31Precursor Cell Lymphoblastic Leukemia-Lymphoma 26Myeloproliferative Disorders 18Congenital Abnormalities 17Leukemia, Lymphocytic, Chronic, B-Cell 16Anemia, Refractory 15Blast Crisis 14Anemia 14Myelodysplastic-Myeloproliferative Diseases 10Lymphoma, Non-Hodgkin 10Leukemia, Myeloid, Chronic-Phase 10Leukemia, Myeloid, Accelerated Phase 9Leukemia, Megakaryoblastic, Acute 9Leukemia, Erythroblastic, Acute 9Neoplasms 8Lymphoma, Follicular 8Lymphoma 8Leukemia, Myelomonocytic, Acute 8Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 8Leukemia, Monocytic, Acute 8Anemia, Aplastic 8Lymphoma, Large B-Cell, Diffuse 7Hodgkin Disease 7Thrombocytopenia 6Multiple Myeloma 6Lymphoma, Mantle-Cell 6

Interventions

Counseling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NIH × Fanconi Anemia, Complementation Group D1 × Classical hematology × Clear all
NCT00858078 2021-11-30

A Qualitative Exploration of the Impact of Positive BRCA1/2 Mutation Status on the Lives of Young Women

National Institutes of Health Clinical Center (CC)

Completed
76 enrolled
Classical hematology

Fanconi Anemia, Complementation Group D1

NCT00001806 2019-12-12

Methods in Education for Breast Cancer Genetics

National Institutes of Health Clinical Center (CC)

Phase 3 Completed
170 enrolled
BreastClassical hematologyGynecologic

Fanconi Anemia, Complementation Group D1, Breast Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡